Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

human epidermal growth factor receptor 2 test

(HYOO-mun eh-pih-DER-mul grothe FAK-ter reh-SEP-ter 2 …)
A laboratory test that measures the amount of HER2 protein on cancer cells or how many copies of the HER2 gene are in the DNA of cancer cells. The HER2 protein helps control normal cell growth. Larger than normal amounts of the HER2 protein or too many copies of the HER2 gene may be made by some types of cancer, including breast, ovarian, bladder, pancreatic, and stomach cancers. This may cause cancer cells to grow more quickly and spread to other parts of the body. A human epidermal growth factor receptor 2 test may be done to help plan treatment, which may include drugs that target the HER2 protein. It is a type of tumor marker test. Also called HER2 test and HER2/neu test.
Search NCI's Dictionary of Cancer Terms